Another Appetite-suppressing Hormone Found

Susan Farley
Published Online: Sunday, January 1, 2006

Joining leptin, melanocortin, and ghrelin in the group of appetite-suppressing hormones is obestatin, which is produced by the same gene that produces ghrelin. Researchers, led by Aaron Hsueh, PhD, of Stanford University, used data gathered by the Human Genome Project in their discovery. Dr. Hsueh found that treating rats with obestatin suppressed their food intake—which opens possibilities to develop the drug for humans, either by injection or possibly a nasal spray. Scientists caution, however, that the effects of obestatin may be limited and may cause an illness or nausea that decreases appetite. To date, research on appetite-suppressing hormones has yet to produce a cure for obesity.

Ms. Farley is a freelance medical writer based in Wakefield, RI.

Latest Articles
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Bryan Ziegler, PharmD, executive director of Kennedy Pharmacy Innovation Center, provides some resources for community pharmacists to use when implementing new collaborative services with primary care providers.
James Schiffer, RPh, associate at Allegaert Berger & Vogel LLC, discusses some tips for pharmacists who are facing a Drug Enforcement Administration audit.
Carlos Aquino, founder and president of PharmaDiversion LLC, talks about the importance of the Drug Enforcement Administration's (DEA) diversion website.
Latest Issues